Variant report
Variant | nsv979336 |
---|---|
Chromosome Location | chr2:78556604-78567711 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:78552005..78554249-chr2:78556086..78558009,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571123639 | chr2:78556706-78556707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192036717 | chr2:78556715-78556716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553137781 | chr2:78556718-78556719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566693402 | chr2:78556746-78556747 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs564414898 | chr2:78556752-78556753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535654501 | chr2:78556758-78556759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs182740353 | chr2:78556805-78556806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531854205 | chr2:78556868-78556869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs62166076 | chr2:78556942-78556943 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs556710231 | chr2:78556945-78556946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577051238 | chr2:78556958-78556959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545745309 | chr2:78556961-78556962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559706701 | chr2:78557019-78557020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528249205 | chr2:78557109-78557110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187762224 | chr2:78557118-78557119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs115222341 | chr2:78557153-78557154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs529798585 | chr2:78557173-78557174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547975822 | chr2:78557176-78557177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10166502 | chr2:78557212-78557213 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs111517333 | chr2:78557213-78557214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs66471817 | chr2:78557214-78557215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192364269 | chr2:78557234-78557235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546839661 | chr2:78557239-78557240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs371181935 | chr2:78557242-78557243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554082146 | chr2:78557243-78557244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs559754477 | chr2:78557250-78557251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530118603 | chr2:78557252-78557253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566829988 | chr2:78557282-78557283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535642239 | chr2:78557311-78557312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549211784 | chr2:78557341-78557342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552174863 | chr2:78557350-78557351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs144958390 | chr2:78557398-78557399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs536779956 | chr2:78557408-78557409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs114500259 | chr2:78557415-78557416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576736831 | chr2:78557433-78557434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs941019 | chr2:78557471-78557472 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs116346259 | chr2:78557500-78557501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs372961841 | chr2:78557514-78557515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs149049757 | chr2:78557565-78557566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542044349 | chr2:78557574-78557575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561894171 | chr2:78557584-78557585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs575680752 | chr2:78557642-78557643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs555953393 | chr2:78557648-78557649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs186753675 | chr2:78557655-78557656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs192320135 | chr2:78557660-78557661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143045479 | chr2:78557667-78557668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546627573 | chr2:78557695-78557696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560408650 | chr2:78557702-78557703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529569396 | chr2:78557706-78557707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs116138758 | chr2:78557716-78557717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Lung cancer | 18438408 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Epilepsy | 22083797 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:78556600-78557800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr2:78557000-78557600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
3 | chr2:78557000-78557600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr2:78557000-78558000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr2:78557200-78557800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr2:78557400-78557600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr2:78557400-78557800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr2:78557400-78557800 | Enhancers | HUES6 Cell Line | embryonic stem cell |